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Abstract
Although a link between excess lipid storage and aberrant glucose metabolism has been recognized for many years,
little is known what role lipid storage droplets and associated proteins such as Plin2 play in managing cellular glucose
levels. To address this issue, the influence of Plin2 on glucose uptake was examined using 2-NBD-Glucose and
[3H]-2-deoxyglucose to show that insulin-mediated glucose uptake was decreased 1.7- and 1.8-fold, respectively in L
cell fibroblasts overexpressing Plin2. Conversely, suppression of Plin2 levels by RNAi-mediated knockdown
increased 2-NBD-Glucose uptake several fold in transfected L cells and differentiated 3T3-L1 cells. The effect of
Plin2 expression on proteins involved in glucose uptake and transport was also examined. Expression of the SNARE
protein SNAP23 was increased 1.6-fold while levels of syntaxin-5 were decreased 1.7-fold in Plin2 overexpression
cells with no significant changes observed in lipid droplet associated proteins Plin1 or FSP27 or with the insulin
receptor, GLUT1, or VAMP4. FRET experiments revealed a close proximity of Plin2 to SNAP23 on lipid droplets to
within an intramolecular distance of 51 Å. The extent of targeting of SNAP23 to lipid droplets was determined by co-
localization and co-immunoprecipitation experiments to show increased partitioning of SNAP23 to lipid droplets when
Plin2 was overexpressed. Taken together, these results suggest that Plin2 inhibits glucose uptake by interacting with,
and regulating cellular targeting of SNAP23 to lipid droplets. In summary, the current study for the first time provides
direct evidence for the role of Plin2 in mediating cellular glucose uptake.
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Introduction
When chronic over-nutrition leading to obesity occurs,
excess lipids that are released from adipose tissue are stored
as ectopic fat in the liver and skeletal muscle (also heart and
pancreas). Increased levels of lipid metabolites such as
diacylglycerols and ceramides impair insulin signaling, resulting
in reduced cellular glucose uptake and insulin sensitivity [1]. To
protect cells from the lipotoxic effects and cellular dysfunction
of lipid metabolites, intracellular lipids are stored in lipid
droplets, vesicles composed of a neutral lipid core surrounded
by a phospholipid monolayer with embedded proteins coating
the surface. Lipid droplets are highly dynamic organelles
involved in various cellular functions [2]. Understanding cell-
specific regulation of lipids reserved in lipid droplets is an active
area of research and cell type often defines the proteins
associated with lipid droplets. The perilipin (Plin) family of
proteins are lipid droplet-associated proteins related through
sequence homology and affinity for lipid droplets [3–5]. Plin1
(formerly known as perilipin) and Plin4 (S3-12) are found
primarily in adipocytes and steroidogenic cells. Plin2 and Plin3
(previously TIP47, M6PRBP) are both ubiquitously expressed
in all cell types with high levels of Plin2 observed in
hepatocytes and skeletal muscle cells. Plin5 (also known as
OXPAT, PAT1, LSDP5), is found primarily in cells with high
energy requirements including myocytes and hepatocytes.
Plin1 and Plin2 are constitutively located on the lipid droplet
surface while Plin 3-5 can be found in both cytosolic and lipid
droplet compartments [6–9]. Plin1 is the most studied lipid
droplet protein with known function involving TG hydrolysis
[3–5], but the full physiological significance of the rest of the
Plin family remains less defined. With regard to Plin2, several
reports describe increased TAG accumulation and lipid droplet
formation when Plin2 is overexpressed in cells [10–13].
Conversely, knockdown of Plin2 in macrophages was shown to
decrease cellular lipids and lipid droplet size and number [10].
In studies with Plin1 knockout mice, Plin2 was up-regulated
and replaced Plin1 on the surface of lipid droplets without
PLOS ONE | www.plosone.org 1 September 2013 | Volume 8 | Issue 9 | e73696
replacing Plin1’s hydrolytic function [14], yet in other work,
Plin2 regulated access of the lipase ATGL (adipose triglyceride
lipase) to the lipid droplet surface to influence TAG hydrolysis
[12]. These results, along with the fact that Plin2 binds lipids
such as cholesterol [15–17], fatty acids [15,18], and
phospholipids [19] with high affinity, suggest that Plin2 may
play an important role in maintaining lipid homeostasis. In
keeping with this, studies with several mouse models revealed
that Plin2 ablation yields mice with reduced hepatic lipids that
are resistant to diet-induced fatty liver and adipose
inflammation [20,21] without changes in TAG synthesis or fatty
acid uptake, synthesis, or β-oxidation. Indirect evidence that
Plin2 is also involved with managing glucose levels comes from
several studies including work with the Zucker diabetic rat
model which showed increased levels of Plin2 in skeletal
muscle correlated with insulin resistance when fed a high fat
diet [22]. Moreover, diabetic patients with increased Plin2
expression exhibited reduced insulin-stimulated glucose uptake
[22]. In other work, mice treated with anti-sense Plin2
oligonucleotides were protected against diet-induced insulin
resistance when fed high fat diets [23]. Chang et al.
demonstrated that mice deficient in Plin2 and crossed with
ob/ob mice showed an improvement in insulin resistance in the
liver and skeletal muscle [24]. However, the presence of an
active Plin2 truncated protein (designated Δ2,3-ADPH) in the
Plin2 knockout model confounded interpretation of this work
[25]. The above studies indicated a connection between altered
Plin2 expression and the development of insulin resistance, yet
direct evidence of Plin2 involvement was not provided. The
present work was undertaken to address this issue by
examining the influence of Plin2 on SNARE-mediated glucose
transport and metabolism.
Of central importance in determining cellular insulin
sensitivity is the ability of cells to take up and utilize glucose.
Cellular glucose uptake is mediated through the action of two
major types of glucose transporters namely: facilitative glucose
transporters (GLUT) and sodium-glucose transporters (SGLT)
[26]. Several isoforms of GLUT exist including the ubiquitously
expressed GLUT1 and also GLUT4, predominantly expressed
in muscles and adipocytes [27] and regulated by insulin
[28,29]. Under basal conditions more than 90% of GLUT4
resides in the cytoplasm within glucose transporter vesicles
(GSV). Upon insulin stimulation these vesicles translocate to,
then dock and fuse with the plasma membrane to enhance
GLUT4 availability and facilitate glucose entry into the cell [30].
These events are mediated by various SNARE proteins that
have also been shown to target to lipid droplets to regulate lipid
droplet fusion and growth [31,32], suggesting that partitioning
of SNARE proteins between lipid droplets and the plasma
membrane represents a potential point of control in the
regulation of both glucose uptake and lipid droplet biogenesis.
Since Plin2 is known to promote lipid droplet formation and
growth [20,33,34], the role of Plin2 in SNARE-mediated
glucose uptake and transport was examined using laser
scanning confocal microscopy, radioligand assays, co-
immunoprecipitation, and FRET techniques. The data
presented herein provides the first direct evidence of the
influence of Plin2 on glucose uptake and SNARE protein
dynamics, in keeping with a key role for Plin2 in glucose
transport and metabolism.
Materials and Methods
Materials
DMEM, 2-NBD-glucose, and Opti-MEM were purchased from
Life Technologies-Invitrogen (Carlsbad, CA). The glucose
transport inhibitor cytochalsin B was purchased from Sigma
(St. Louis, MO). [3H]-2-deoxyglucose was purchased from
American Radiochemicals Inc., (Saint Louis, MO).
Commercially available polyclonal antibodies made in rabbit
were purchased from the following vendors: anti-Syntaxin-5
and mouse monoclonal anti-VAMP-4 were from Santa-Cruz
biotechnologies (Santa-Cruz, CA); anti-SNAP23 was from
Abcam (Cambridge, MA); anti-insulin receptor was from
Abbiotech, LLC (San Diego, CA); anti-Plin1 was purchased
from Thermo Scientific-Affinity Bioreagents (Rockland, IL), and
anti-FSP27 was from Lifespan Biosciences (Seattle, WA). Anti-
rabbit polyclonal anti-serum to Plin2 was developed in house
as described earlier [35]. Anti-GLUT1 used for
immunoprecipitation experiments and immunoblotting was from
Fabgennix (Frisco, TX) and Epitomics (Burlingame, CA),
respectively. Goat anti-SNAP23 polyclonal used in
immunofluorescence studies was purchased from Everest
Biotech (Ramona CA). The Cy3-labeled anti-goat secondary
antibody used for FRET studies was purchased from Jackson
Immuno Research Laboratories, Inc. (West Grove, PA) while
the Cy5-labeled anti-rabbit secondary antibody was from Life
Technologies-Invitrogen (Carlsbad, CA). All reagents and
solvents used were of the highest grade available and were cell
culture tested.
Cell Culture
L cell fibroblasts were derived from NCTC clone 929 (L cell,
derivative of Strain L, ATCC® CCL-1™). Cells were maintained
in high glucose DMEM containing 10% FBS and antibiotics
(100 units/ml penicillin and 100 units/ml streptomycin) under
5% CO2 at 37oC. Plin2 overexpressing L cells were generated
by stable transfection using a plasmid containing the full coding
region of mouse Plin2 cDNA N-terminally fused to CFP as
described elsewhere [13]. It should be noted that the N-
terminal CFP tag had no effect on Plin2 targeting to lipid
droplets as assessed by laser scanning confocal microscopy,
consistent with earlier reports [34]. Mock-transfected control
cells (designated as controls) were created by stable
transfection into L cells using the empty CFP vector. For
glucose uptake studies, control cells were seeded in 2-well
chamber slides (Nunc, Naperville, IL) at a density of 5x105
cells/well. Undifferentiated 3T3-L1 pre-adipocytes (ATCC®
CL-173™) were maintained in DMEM containing 10% FBS and
antibiotics (100 units/ml penicillin and 100 units/ml
streptomycin) under 5% CO2 at 37oC. For glucose uptake
studies and protein analysis with 3T3-L1 cells, preadipocytes
were differentiated into adipocytes following standard
procedures. In brief, confluent 3T3-L1 cells were maintained in
the presence of serum containing DMEM supplemented with
dexamethasone (1 µM), methylisobutylxanthine (500 µM) and
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insulin (1 µg/ml) for 48 hrs and then switched to DMEM
containing insulin (1 µg/ml), replacing media every 48 hrs. After
6 days, the majority of cells were differentiated into adipocytes.
Lipid analysis
Neutral lipids were extracted from CFP-ADRP and control
cell homogenates and resolved into individual lipid classes as
described earlier [36,37]. In brief, samples extracted with n-
hexane: 2-propanol 3:2 (v/v) were resolved by lipid groups into
cholesterol (Chol), free fatty acids (FFA), triacylglycerol (TG),
cholesteryl esters (CE), and total phospholipids (PL) using
Silica gel G TLC plates developed in petroleum ether-diethyl
ether-methanol-acetic acid (90:7:2:0.5, v/v/v/v). For resolution
of diacylglycerols (DG), the following solvent system was used:
petroleum ether-diethyl ether-glacial acetic acid (280:120:4
v/v/v/v). All lipids were identified by comparison to known
standards. Levels of neutral lipids, (DG, TG, CE) were
analyzed by the method of Marzo et al. [38]. Protein
concentration was determined by the method of Bradford from
the dried protein extract residue digested overnight in 0.2 M
KOH [39]. Lipids were stored under an atmosphere of N2 to
limit oxidation and all glassware was washed with sulfuric acid-
chromate before use.
2-NBD-Glucose uptake
Glucose uptake studies were performed on cells (transfected
L cell fibroblasts or differentiated 3T3-L1 cells) with altered
Plin2 levels using the fluorescent glucose analogue, 2-NBD-
Glucose, at room temperature using a modification of methods
described elsewhere [40,41]. In brief, cells grown in 2-well
chamber slides were washed twice with phosphate-buffered
saline and placed on an Olympus FluoView 1000 Laser
Scanning Confocal Microscope (Olympus, America, Inc.,
Center Valley, CA) equipped with an IX81 automated inverted
microscope and operated with Fluoview software. To acquire
images, fluorescent probes were excited using the FluoView’s
488nm Argon ion laser for NBD label and the 458 nm Argon
line for CFP. Fluorescence emission of 2-NBD-Glucose was
collected using a 505-525 nm band pass filter. During image
acquisition, cells were exposed to the light source for minimal
time periods to minimize photobleaching effects. A field of
20-25 cells was selected for analysis and 2-NBD-Glucose (50
µM) was added to start the uptake process. During the time
course, real time fluorescent images were acquired every 30
seconds until saturation was reached. Uptake into the cell was
measured as an increase in 2-NBD-Glucose fluorescence
intensity inside the cell using Metamorph image analysis
software (Molecular Device, Sunnyvale, CA). Exclusive
thresholding of levels were adjusted to remove the extracellular
fluorescence. Intensity values were plotted using Sigmaplot
11.0 (Systat Software, Inc., San Jose, CA) and curve-fitted by
non-linear regression analysis using the following formula f = a
(1-e-bt) where “a” represented the Fmax, corresponding to the
maximal capacity of glucose uptake; “t” was time, and “b” was
the apparent rate constant, representing the rate of approach
to Fmax. Initial rates were calculated from the linear portion of
the 2-NBD-Glucose uptake curve (0-5 min) fitted by linear
regression analysis.
Radioactive 2-deoxyglucose uptake
Glucose uptake was studied using [3H]-2-deoxyglucose
following the method of Nedachi et al. [42]. Briefly, L cell
control and Plin2 overexpression cells were plated in 6 well
dishes (105 cells/well) and serum starved overnight. Cells were
washed twice with Krebs-Ringer-HEPES (KRH) buffer and
uptake was initiated by the addition of radioactive stock
solution (19.5 mM cold 2-deoxyglucose with 5 µCi/ml [3H[-2-
deoxyglucose) to give a final concentration of 6.5 mM 2-
deoxyglucose (0.5 µCi [3H[-2-deoxyglucose/well) in each well.
After 5 minutes, the reaction was stopped by addition of ice
cold KRH buffer. Cells were washed three times with ice-cold
KRH buffer, then lysed with lysis buffer (10 mM Tris pH 7.4,
150 mM NaCl, 5 mM EDTA, 1.0% triton X-100, 0.4% SDS) and
collected to measure radioactivity per well.
Cytochalasin B, glucose, and insulin effects on 2-NBD-
Glucose uptake in L cell fibroblasts
Glucose uptake was performed in the presence of either
cytochalasin B, a well-known glucose transport inhibitor [43],
unlabeled D-glucose, or insulin to examine the mechanism of
glucose uptake in L cells. To determine if glucose uptake in L
cells was GLUT-mediated, 2-NBD-Glucose (50 µM) was added
to cells pre-treated with and without cytochalasin B (100 µM)
for 30 minutes and fluorescence intensity was measured at
time 0 and 30 min after addition of 2-NBD-Glucose. Relative
integrated intensities were calculated as described in the
previous section. Competitive inhibition of 2-NBD-glucose
uptake by excess unlabeled D-glucose was examined by
incubating cells with 2-NBD-glucose and D-glucose (25mM) for
30 minutes. Next, to determine if glucose uptake in L cells was
insulin-induced, 2-NBD-Glucose uptake in cells pre-treated with
insulin (100 nM) for 30 minutes followed by addition of 2-NBD-
Glucose (50 µM). Fluorescent images were acquired for 30
minutes. Increases in fluorescence intensity, Fmax and initial
rate were calculated as described above.
Western blot analysis
Expression levels of proteins involved in glucose transport
(insulin receptor, GLUT1), lipid droplet function (Plin2, Plin1,
FSP27), and vesicular transport (VAMP4, SNAP23, syntaxin-5)
were assessed by Western blot analysis and normalized to the
mean expression of GAPDH as described in [44]. For each
blot, equal amounts of cell homogenate (15-20 µg protein,
depending on the cellular expression level of the protein of
interest) was loaded onto tricine gels (10%) and run on a Mini-
Protean II cell (Bio-Rad lab, Hercules, CA) system at constant
amperage (30 mA per gel) for approximately 1.5 to 2 hrs.
Proteins were then transferred electrophoretically to
nitrocellulose membranes (Bio-Rad) at constant voltage (90 V)
for 1.5 hrs. After transfer, the blots were stained with Ponceau
to confirm protein transfer and constant protein loading [45,46].
Blots were then processed using the Western Breeze
Chemiluminescent Immunodetection kit (Life technologies-
Invitrogen, Carlsbad, CA) to detect relative levels of the protein
of interest and a housekeeping gene (GAPDH or actin)
following the manufacturer’s instructions. Scanned images of
the Western blots (8-bit gray scale density) were used for
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densitometric analysis using NIH Scion Image to obtain relative
protein levels expressed as integrated density values. The
integrated density, representing the mean density of pixels
multiplied by the area was determined from equal sized
rectangles drawn around the bands of interest minus the
background to remove non-specific antibody staining.
RNA Interference (siRNA)
Plin2 siRNA (sense-5′-AACGUCUGUCUGGACCGAAUA-3′
and the corresponding antisense) sequences described in [47]
were synthesized from Dharmacon (Lafayette, CO). A non-
targeting control siRNA was purchased from Dharmacon. In L
cells, the siRNA transfection was performed using opti-MEM
and lipofectAMINE 2000 as per the manufacturer’s instructions.
Briefly, cells (0.4 x 106 cells/ well) in 6-well plates (Nunc,
Naperville, IL) were transfected with either the non-targeting
control siRNA (50 nM) or the Plin2 siRNA (50 nM).
Untransfected control cells plated at the same density were
maintained simultaneously. Six hours after transfection, the
media was changed to complete growth medium. With
differentiated 3T3-L1 cells, the siRNA transfection was
performed with control or Plin2 siRNA (20 nM) using DeliverX
plus siRNA reagent (Affymetrix, Santa Clara, CA) following the
manufacturer’s protocol. One well for each treatment in both L
cells and 3T3-L1 cells was trypsinized and seeded into 2-well
chamber slides and 6-well plates for uptake studies and
Western blotting, respectively at 48 hrs (3T3-L1 cells) or 72
hours (L cells) post transfection.
Colocalization and fluorescence resonance energy
transfer (FRET) imaging
The intracellular localization and partitioning of SNAP23 with
Plin2 and GLUT1 was examined by colocalization and FRET
imaging studies following procedures described earlier [13,15].
Briefly, the colocalization studies were performed with Plin2
overexpression and control cells seeded at a density of 50,000
cells/well in 4-well chamber slides (EZ Slide, Millipore, Billerica,
MA) incubated overnight at 37°C. The cells were fixed using
cold acetone/ethanol (70: 30 v/v) and washed with PBS. The
cells were blocked with 2% BSA and then incubated with
primary antibodies for 1 hr at room temperature with either goat
anti-SNAP23 (1:25) and rabbit anti-Plin2 (1:50) or goat anti-
SNAP23 (1:25) and rabbit GLUT1 (1:25). After extensive
washing with PBST (0.05% Tween100 in PBS), a mixture of
secondary reagents consisting of Cy3 or Cy5 labeled
secondary antibodies (at 1:100 dilutions) in PBS was added to
each set and incubated for 1 hr at room temperature. Cells
were then washed with PBS and mounted with coverslips using
fluorogel mounting medium (Electron Microscopy Science,
Hatfield, PA). Cells were also stained with Cy3 and Cy5 alone
in the absence of primary antibodies as a standard control. Cell
images were sequentially acquired on an Olympus FluoView
1000 Laser Scanning Confocal Microscope using 559 nm
excitation, 575/50 filter (green channel) to view the Cy3
emission and 635 nm excitation, 725/30 filter (red channel) for
the Cy5 emission. Co-localization of the Cy3- and Cy-5 signals
was obtained using the Olympus Fluoview software where the
confocal images from the green and red channels were merged
and appeared yellow where superimposition occurred (red and
green are additive and yield yellow to orange in RGB color
space). The percentage of green and red co-localization in
cells was calculated based on the following equations:
Cred =
∑
i
Ri,coloc
∑
i
Ri
Cgreen=
∑
i
Gi,coloc
∑
i
Gi
where Σ Ri,coloc is the sum of intensities of all red pixels which
also have a green component; ΣRi is the sum of intensities of
all red pixels in the image; ΣGi,coloc is the sum of intensities of all
green pixels which also have a red component; and ΣGi is sum
of intensities of all the green pixels in the image.
For the FRET imaging studies, cells were processed as for
the co-localization studies to measure the increase in donor
(Cy3) emission upon photobleaching of the acceptor (Cy5) as
described in [13]. In brief, the FRET experiment was performed
by measuring the fluorescence emission of the Cy3 donor
through the 575/50 nm filter upon excitation at 559 nm before
and after photobleaching of the Cy5-acceptor at 633 nm.
Before performing the FRET experiment multiple controls were
used to avoid interference from non-specific fluorescence: (i)
Non-labeled cells were used to set the gain and black level in
the Cy3 channel so that no cellular autofluorescence was
detected in the donor Cy3 channel while maintaining maximum
dynamic range; (ii) Cells labeled with Cy5 were excited at 559
nm to show no observed fluorescence in the donor Cy3
channel by adjusting the gain and black level in Cy5 channel to
suppress Cy3 fluorescence bleed-through; and (iii) Donor cells
(Cy3-labeled) without Cy5 present were subjected to bleaching
to check for non-specific fluorescent increases in the donor
channel and also to optimize bleaching parameters so that the
donor intensity was not affected by bleaching. Additionally, one
or two cells during the FRET experiment were left unbleached
to serve as in-field bleaching control. To calculate the FRET
efficiency (E), representing the efficiency of energy transfer
between donor and acceptor, the following equation was used:
E = 1-(IDA/ID) where IDA is donor fluorescence intensity before
acceptor photobleaching and ID is the donor fluorescence
intensity after acceptor photobleaching. An average E value
was calculated from Cy3 fluorescence emission increase after
photobleaching. The intermolecular distance R between
SNAP23 and Plin2 or SNAP23 and GLUT1 was calculated
from the equation E = 1/(1-(R/Ro)6), where E is experimentally
determined and Ro is the Foster radius for the Cy3-Cy5 FRET
pair, previously determined as 51 Å. For the FRET efficiency
images, analysis was performed in MetaMorph 7.5 (Molecular
Devices, Sunnyvale, CA) as described in with images filtered to
remove randomized noise by using a low pass filter using a 4 x
4 pixel setting. The filtered images of the donor emission
before acceptor photobleaching were subtracted from the
image after acceptor photobleaching. The resultant image was
divided by the image of donor emission after acceptor
photobleaching and multiplied by 100 to show the grayscale
FRET efficiencies. A FRET overlay was created from this
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image and pseudo-colored in order to visualize regions of
higher and lower FRET where black indicated little to no
efficiency and red to yellow represented efficiencies greater
than 80%.
Co-immunoprecipitation studies
The Catch and Release v2.0 system from Millipore (Billerica,
MA) was used for co-immunoprecipitation (co-IP) studies
following the manufacturers’ protocol. Briefly, cell lysates from
Plin2 overexpressing or control cells were incubated with the
spin column resin, specific antibody (1-4 µg), and the antibody
affinity capture ligand provided in the kit (10 µl) overnight at 40C
with shaking. The following day, unbound fractions were
separated by centrifugation, followed by washing and the
bound complex was eluted. Eluate proteins were analyzed by
Western blotting with n=3 blots for each co-IP. A negative
control (rabbit IgG) was used to assess nonspecific binding.
Statistical Analysis
All values were expressed as the means ± S.E. Student’s t
tests were performed when comparisons are made between
two groups using Graphpad Prism (San Diego, CA). When
more than two groups were compared one-way analysis of
variance (ANOVA) followed by multiple comparison test using
the Holm-Sidak method. Values with p < 0.05 were considered
statistically significant.
Results
Dose dependence of 2-NBD-Glucose uptake in mouse L
cell fibroblasts
The dose dependence of 2-NBD-glucose uptake was
performed using laser scanning confocal microscopy (LSCM)
on L cell fibroblasts. Despite their fibroblast-like morphology, L
cells provide a useful model to study glucose uptake and
transport since they were derived from mouse subcutaneous
adipose and areolar tissue (ATCC number CCL-1) and contain
all the necessary machinery for glucose utilization [48] and
cellular metabolism [49–54] to mimic similar cell types
commonly used to study glucose metabolism. Additionally, the
large data set of information available and the fact that the
abundance of Plin2 in L cells could easily accommodate
increased or decreased expression without issues of cell
toxicity or lack of detection made L cells the model of choice.
Representative images of L cells labeled with 2-NBD-Glucose
for 20 min at each concentration (25-300 µM) is shown in
Figure 1A. 2-NBD-Glucose uptake at increasing concentrations
of the probe was assessed over 30 min to determine the
optimal concentration of 2-NBD-glucose before saturation
(Figure 1B). Fmax, corresponding to the maximal capacity of
glucose uptake (Figure 1C) and the initial rate of uptake (Figure
1D) was observed to increase up to 2-fold when L cells were
incubated with 25 µM to 200 µM 2-NBD-glucose. At levels
above 200 µM no further increase was observed in either Fmax
or initial rates, indicating that the process had reached
saturation. As a result, a concentration mid-phase in the linear
increase (50 µM) was chosen for subsequent glucose uptake
studies.
Effect of the GLUT inhibitor cytochalasin B and insulin
on 2-NBD-Glucose uptake in L cell fibroblasts
Since glucose uptake is mediated through the action of
glucose transporters [26], it was important to verify that the
fluorescent glucose analogue 2-NBD-Glucose was GLUT-
mediated in our L cell model. Therefore, 2-NBD-Glucose
uptake studies were performed in the presence or absence of
the glucose transporter inhibitor, cytochalasin B [43] and the
extent of uptake was calculated as described in the Methods
section. Analysis of multiple experiments revealed that 2-NBD-
Glucose uptake was significantly reduced 65% (p < 0.001) in
the presence of cytochalasin B, in keeping with a GLUT-
mediated mechanism (Figure 1E). Moreover, in the presence of
D-glucose 2-NBD-Glucose uptake was significantly reduced
(Figure 1E), suggesting that the excess unlabeled glucose was
able to competitively inhibit 2-NBD-glucose. These results
further confirmed 2-NBD-glucose uptake was mediated through
the physiological glucose transport system. The effect of
insulin, a known physiological stimulator of glucose uptake, on
2-NBD-Glusose uptake was next examined. Since L cells
contain both high and low affinity insulin binding sites [54] it
was not surprising to see that insulin treatment induced a 1.6-
fold increase in 2-NBD-Glucose uptake (Figure 1E, p < 0.05).
Taken together, these results indicated that 2-NBD-Glucose
uptake in L cells was insulin responsive and GLUT-mediated.
Effect of altered Plin2 expression on 2-NBD-Glucose
uptake in transfected L cells
To examine the effect of Plin2 on cellular glucose uptake, 2-
NBD-Glucose uptake was performed in cells with altered Plin2
expression. Plin2 overexpression cells were developed by
stably transfecting L cells with mouse cDNA encoding for CFP-
labeled Plin2 as described earlier [13]. Lipid droplets in control
cells transfected with the empty vector were visible by light
microscopy (Figure 2B) but exhibited little to no fluorescence
above background (Figure 2A). In contrast, transfection of L
cells with CFP-Plin2 construct resulted in fluorescently labeled
lipid droplets (Figure 2C) that were also able visible by light
microscopy (Figure 2D). These results demonstrated that the
N-tagged CFP-Plin2 did not affect lipid droplet targeting,
consistent with previous reports in 3T3-L1 cells with GFP-
labeled Plin2 [34]. Levels of Plin2 in the transfected clones
were 1.8-fold higher than mock-transfected L cells as shown by
Western blotting using antibodies against Plin2 (Figure 2E,
p<0.01). A similar fold increase (1.6-fold) was observed using
antibodies against CFP to detect the CFP-labeled Plin2 (data
not shown). In addition, levels of neutral lipids (diacylglycerols,
triacylglycerols, cholesteryl esters) were significantly increased
1.4-fold in the Plin2 overexpression cells (Figure 2F, p<0.05),
consistent with previous reports in other cell types [11,13,34].
When Plin2 overexpressing cells were incubated with 2-NBD-
Glucose, analysis of multiple uptake experiments showed a
70% reduction in 2-NBD-Glucose uptake (p < 0.001) as
compared to mock-transfected control L cells (Figure 3A).
These results reflected a 42% decrease in Fmax and a 53%
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Figure 1.  Dose response and effect of cytochalsin B and insulin on 2-NBD-Glucose uptake into L cells.  Representative
confocal images of L cells labeled with different doses of 2-NBD-Glucose (50-300 µM) are shown (A). Uptake of 2-NBD-Glucose (B)
and the time-course parameters Fmax (C) and initial rate (D) were calculated as described in the Methods section. The effect of the
glucose transport protein inhibitor, cytochalsin B, insulin, and unlabeled glucose on 2-NBD-Glucose uptake after 30 min incubation
was determined (E). Increases in fluorescence intensity were calculated and expressed as arbitrary units (a.u.). Values represent
mean ± SEM. (*) indicates p < 0.05 as compared to control.
doi: 10.1371/journal.pone.0073696.g001
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decrease in the initial rate of cellular 2-NBD-Glucose uptake.
Parallel studies with [3H]-2-deoxyglucose confirmed these
results (Figure 3B). To verify the Plin2 inhibitory affect on
glucose uptake, RNAi-mediated knock down of Plin2 in L cells
(Figure 3C) and in differentiated 3T3-L1 cells (Table 1) was
performed followed by glucose uptake experiments (Figure
3D). A significant 35% reduction in Plin2 expression in L cells
transfected with Plin2 siRNA (Figure 3C, P < 0.05, n=3)
resulted in a 1.9-fold increase in 2-NBD-Glucose uptake after
30 min (Figure 3D, Table 1, p<0.05). Initial rates were similarly
increased in the knock down cells (Table 1, p < 0.05). Control
siRNA cells did not show increased glucose uptake but were
comparable to those performed with untransfected control cells
(Table 1), indicating that the associated increase in uptake
observed with Plin2 knock down cells was Plin2-specific. To
verify that results with L cells were not cell specific, Plin2 was
knocked down in differentiated 3T3-L1 cells, an established
model of adipocytes and 2-NBD-Glucose uptake experiments
were repeated. Similar to L cells, Plin2 knock down in
differentiated 3T3-L1 cells resulted in a 3-fold increase in 2-
NDB-Glucose maximal uptake and initial rate of uptake (Table
1, p < 0.05). In summary, studies with Plin2 overexpression
cells confirmed that increased Plin2 expression inhibited
GLUT-mediated 2-NBD-Glucose uptake into L cells.
Conversely, RNAi-mediated reduction of Plin2 significantly
increased cellular 2-NBD-Glucose uptake in both L cells and
3T3-L1 differentiated cells. Taken together, these results
indicated a negative correlation between Plin2 expression and
cellular glucose uptake.
Effect of Plin2 overexpression on key proteins involved
in lipid droplet formation and glucose uptake and
transport
To explore the role Plin2 may play in regulating cellular
metabolism, Western blot analyses were performed using
antibodies against the following proteins: insulin receptor
(Figure 4A), Plin1 (Figure 4), GLUT1 (Figure 4C), FSP27
(Figure 4D), SNAP23 (Figure 4E), syntaxin-5 (Figure 4F) and
VAMP4 (data not shown). Based on the results from multiple
Western blots, it was demonstrated that expression levels of
the insulin receptor, Plin1, GLUT1 (the primary glucose
transporter in L cells), FSP27, and VAMP4 were not
significantly changed in Plin2 overexpression cells when
compared to control cells. In contrast, levels of SNAP23 were
increased 1.6-fold (p< 0.001) while syntaxin-5 was reduced 1.7
fold (p < 0.01). Since SNAP23, along with syntaxin-5 and
VAMP4, is involved in the docking and fusion of glucose
transporter vehicles to plasma membrane [30] increased
expression of SNAP23 would be expected to enhance glucose
uptake, not inhibit as was observed in the present work. On the
other hand, decreased expression of syntaxin-5 was more in
line with results found in skeletal muscle where decreased
syntaxin-5 was shown to impair glucose uptake [32]. Since
SNAP23, syntaxin-5, and VAMP4 are present not only at the
plasma membrane but also on the lipid droplet surface and are
implicated in lipid droplet fusion and growth [32], it may be
suggested that expression levels were not as important as the
localization and partitioning of these proteins in the cell. In
summary, cellular glucose uptake was significantly inhibited in
cells overexpressing Plin2, effects that could not be attributed
to changes in levels of the insulin receptor, GLUT1, or other
lipid droplet-associated proteins including FSP27 and Plin1.
Intracellular localization and FRET analysis of SNAP23
with Plin2 or GLUT1
The intracellular localization and targeting of SNAP23 with
Plin2 and GLUT1 was examined next in a series of co-
localization and FRET imaging experiments in order to
determine: (i) the localization and partitioning of SNAP23 in the
cell and (ii) the effect of Plin2 overexpression on SNAP23
intracellular localization. Simultaneous acquisition of confocal
images of Cy3-labeled SNAP23 (green channel) with Cy5-
labeled Plin2 (red channel) in control L cells revealed areas of
high intensity, co-localized signals (yellow-to-orange) that were
identified by morphology as lipid droplets (Figure 5A). In the
representative pixel fluorogram, the correlation coefficient
showed approximately 93% of the Cy5-labeled Plin2 (red) co-
localized with the Cy3-labeled SNAP23 (green), while only 46%
of Cy3-SNAP23 co-localized with the Cy3-labeled Plin2 (Figure
5B). As Plin2 localized primarily on the lipid droplet surface,
these results indicated that SNAP23 targeted to lipid droplets
as well as other intracellular locations. Similarly, control L cells
were labeled with Cy3-SNAP23 (green) and Cy5-GLUT1 (red)
to show co-localization in cytosolic and plasma membrane
compartments of the cells as yellow to orange staining in areas
of overlap (Figure 6A). From the representative pixel
fluorogram (Figure 6B) approximately 55% of the Cy5-labeled
GLUT1 (red) co-localized with the Cy3-labeled SNAP23
(green), while 93% of Cy3-SNAP23 (green) co-localized with
Cy5-GLUT1 (red). Taken together, these results indicated that
the majority of SNAP23 co-localized with GLUT1 but GLUT1
could also be found in areas without SNAP23 present.
Over all, the data pointed to a strong spatial overlap between
SNAP 23 and Plin2 and also with SNAP23 and GLUT1 to
within the limits of optical resolution (2,200 Å). However, co-
localization studies could not provide the optical resolution to
infer whether these proteins were in close enough proximity to
interact and/or co-exist in a complex. Therefore, fluorescence
Table 1. Effect of Plin2 knock down on 2-NBD-Glucose
uptake in L cells and differentiated 3T3-L1 cells.
Cells L-cells 3T3-L1 cells
 Fmax(a.u.)
Initial Rate
(sec-1) Fmax(a.u.)
Initial Rate
(sec-1)
Untransfected
control 1257 ± 18 0.23 ± 0.01 918 ± 19 0.15 ± 0.01
Control siRNA 1313 ± 20 0.21 ± 0.01 841 ± 7 0.10 ± 0.08
Plin2 siRNA 2433 ± 38*  0.52 ± 0.01* 3118 ±187*  0.5 ± 0.1*
The effects of Plin2 knock down on 2-NBD-glucose uptake parameters, Fmax and
initial rate, were determined as described in Method section. Increases in
fluorescence intensity were calculated and expressed as arbitrary units (a.u.).
Values represent mean ± SEM. (*) indicates p < 0.05 as compared to
untransfected control cells.
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Figure 2.  Effect of Plin2 overexpression in transfected Lcells.  L cells were transfected with empty vector to show little to no
fluorescence in lipid droplets (A) that were evident by light microscopy (B). Lipid droplet targeting of the CFP-Plin2 construct was
confirmed by confocal microscopy showing CFP-labeled lipid droplets in Plin2 overexpressing cells (C) that were also visible by light
microscopy (D). Relative expression of Plin2 (E) and neutral lipid content (F) in control (open bar) and Plin2 overexpression (closed
bar) cells were measured as described in Methods. (*) indicates p<0.05 as compared to control. Insets: Representative Western
blots showing relative protein expression of Plin2 and GAPDH in control and Plin2 overexpression cells.
doi: 10.1371/journal.pone.0073696.g002
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Figure 3.  Effect of altered Plin2 expression on 2-NBD-Glucose uptake in L cells.  2-NBD-Glucose uptake (A) in Plin2
overexpression (closed circles) and control (open circle) cells was measured as an increase in fluorescence intensity expressed in
arbitrary units (a.u.) as described in the Methods section. [3H]-2-deoxyglucose uptake (B) was measured in control (open bar) and
Plin2 overexpression (closed bar) cells as a fold-change in radioactivity relative to control cells. Relative expression levels of Plin2
after siRNA-mediated Plin2 knock down (C) and 2-NBD-Glucose uptake (D) in cells that were untransfected (closed circles), treated
with control siRNA (open circle), or Plin2 siRNA (closed square) was also measured, normalized to the housekeeper gene GAPDH.
Values represent mean ± SEM (n=3). (*) indicates p < 0.05 as compared to control. Insets: Representative Western blots showing
relative protein expression of Plin2 and GAPDH.
doi: 10.1371/journal.pone.0073696.g003
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Figure 4.  Relative expression levels of key proteins involved in lipid droplet formation, glucose uptake and transport.  Cell
homogenates from Plin2 overexpressing and control cells were probed with antibodies against the following proteins: insulin
receptor (A), Plin1 (B), GLUT1 (C), FSP27 (D), SNAP23 (E), and syntaxin-5 (F). Expression levels were quantified as described in
the Method section, normalized to the housekeeper gene GAPDH. Values represent mean ± SEM (n=3-5). (*) indicates p < 0.01
and (**) indicates p < 0.001 as compared to control. Insets: Representative Western blots showing relative protein expression of
proteins of interest and housekeeping gene (GAPDH or actin).
doi: 10.1371/journal.pone.0073696.g004
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Figure 5.  Co-localization and FRET imaging between Cy3-labeled SNAP23 and Cy5-labeled Plin2.  Confocal images of Cy3-
labeled SNAP23 and Cy5-labeled Plin2 were examined to determine co-localization (A) and FRET efficiencies, E between the
fluorescently labeled proteins. The extent of co-localization was shown graphically in a pixel fluorogram (B) to reveal Cy3-SNAP23
(arbitrarily placed in the green channel) co-stained with Cy5-Plin2 (red channel) in yellow-to-orange areas where both probes co-
localized. FRET efficiency maps were generated from the following images: donor emission image of Cy3-SNAP23 co-labeled with
Cy5-Plin2 before acceptor (Cy5-Plin2) photobleaching (C); donor emission image of Cy3-SNAP23 co-labeled with Cy5-Plin2 after
acceptor photobleaching (D); donor emission image of Cy3-SNAP23 after photobleaching overlaid with a pseudo-colored FRET
image (E); and acceptor emission image of Cy5-Plin2 after photobleaching (F). Cells were imaged and FRET efficiency images
generated as described in the Method section. The FRET overlay was pseudo-colored to visualize regions of higher and lower
FRET as shown by the inset color scale (E).
doi: 10.1371/journal.pone.0073696.g005
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Figure 6.  Co-localization and FRET imaging between Cy3-labeled SNAP23 and Cy5-labeled GLUT1.  Confocal images of
Cy3-labeled SNAP23 and Cy5-labeled GLUT1 were examined by laser scanning confocal microscopy. Co-localization of Cy3-
SNAP23 (green) with Cy5-GLUT1 (red) revealed yellow-to-orange areas where both probes overlapped (A). The extent of co-
localization was shown in a pixel fluorogram (B). FRET efficiency maps were generated from the following images: donor emission
image of Cy3-SNAP23 co-labeled with the acceptor Cy5-GLUT1 before photobleaching (C); donor emission image of Cy3-SNAP23
co-labeled with Cy5-GLUT1 after acceptor photobleaching (D); donor emission image of Cy3-SNAP23 after photobleaching overlaid
with a pseudo-colored FRET image (E); and acceptor emission image of Cy5-GLUT1 after photobleaching (F). Cells were imaged
and FRET efficiency images generated as described in the Method section. The FRET overlay was pseudo-colored to visualize
regions of higher and lower FRET as shown by the inset color scale (E).
doi: 10.1371/journal.pone.0073696.g006
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resonance energy transfer (FRET) studies were performed as
described in [13,55] to measure direct protein–protein
interactions at the subcellular level to within 10-100 Å. FRET
was measured as the increase in donor (Cy3-labeled SNAP23)
emission upon photobleaching of the acceptor (Cy5-labeled
Plin2 or GLUT1). For the Cy3-SNAP23/Cy5-Plin2 FRET
experiment, emission of the Cy3-labeled SNAP23 was imaged
by exciting the Cy3 label at 559 nm excitation (Figure 5C)
followed by exciting the cells at 633 nm to image the emission
of Cy5-labeled Plin2 (Figure 5D) with fluorescence bleed-
through to other channels minimized as necessary. Cells in the
desired field (indicated by the white boxed region in Figure 5F)
were then photobleached by repeated scanning at 633 nm until
no Cy5 signal was detected (Figure 5F). Photobleaching
neither affected the photostability of the donor nor caused any
non-specific increase in donor density as measured in cells
labeled with the donor alone and subjected to acceptor
photobleaching (data not shown). One cell was left outside the
photobleached area to serve as a bleaching control. FRET was
measured by comparing the Cy3 emission intensities before
(Figure 5C) and after (Figure 5D) photobleaching as described
in the Methods section. The mean FRET efficiency E and
distance R between SNAP23 and Plin2 were calculated to
equal 49 + 1% and 51.3 + 0.4 Å, respectively (Table 2)
indicating the close proximity of SNAP23 to Plin2 in the cell.
FRET efficiency images (Figure 5E, color overlay) were
generated next in order to visualize the areas of the cell where
FRET occurred. FRET efficiencies (E) were scaled to visualize
regions of lower (black to blue) and higher (green to yellow)
FRET (Figure 5E, inset color scale). With Cy3-SNAP23/Cy5-
Plin2 labeled cells, areas of high intensity identified by
morphology as lipid droplets showed E in the range of 45-50%
(blue to cyan on the FRET inset color scale), consistent with
the measured value of the mean E equal to 49%. In similar
fashion, FRET was performed on cells labeled with Cy3-
SNAP23/Cy5-GLUT1 (Figure 6), where the mean E and R
were calculated as 27 + 1% and 60.4 + 0.3 Å, respectively
(Table 2). FRET efficiency images were generated to show
FRET occurring between SNAP23 and GLUT1 in more diffuse
areas of the cytoplasm outside lipid droplets (Figure 6E) with E
equal to 25-30% (blue on the FRET inset color scale). Taken
together, these results indicated that SNAP23 interacted
directly with Plin2 at the lipid droplet surface and GLUT1 in the
cytoplasm as it partitioned between lipid droplets and the
plasma membrane, but was in closer proximity with Plin2
(p<0.001, Table 2).
Table 2. FRET efficiency E and distance R between Cy3
labeled SNAP23 and Cy5-labeled Plin2 or GLUT1.
FRET Pair E (%) R (Å)
SNAP23/Plin2 49 ± 1* 51.3 ± 0.4*
SNAP23/GLUT1 27 ± 1 60.4 ± 0.3
FRET efficiency E and distance R values were determined as described in the
Method section. Values are mean + SE; n = 45-60 cells. (*) indicates p < 0.001 as
compared to the SNAP23/GLUT1 FRET pair.
Effect of Plin2 overexpression on SNAP23 partitioning
between lipid droplets and the plasma membrane
SNARE proteins like SNAP23 (also syntaxins and VAMP4)
play a critical role in moving GLUT vesicles to the plasma
membrane and are also present at the surface of lipid droplets
[32]. In the present work levels of SNAP23 were increased in
the Plin2 overexpression cells, results counterintuitive to the
observed inhibition of glucose uptake. Since the amount of
SNAP23 available may be less important than the location of
SNAP23 in the cell, co-localization and co-immunoprecipitation
(co-IP) techniques were performed to determine the extent of
SNAP23 overlap with Plin2 in lipid droplets versus GLUT1 in
the cytoplasm/plasma membrane when Plin2 expression was
increased. For the co-IP experiments, cells were
immunoprecipitated with the GLUT1 antibody in control cells
(Figure 7, lane 1) and Plin2 overexpression cells (Figure 7,
lane 2) and then immunoblotted with anti-SNAP23 to show that
interactions between SNAP23 and GLUT1 were decreased
significantly 42% (p < 0.5) in Plin2 overexpression cells (Figure
7A; lanes 1 vs 2, Figure 7C). Cells were also immunoblotted
with the GLUT1 antibody to show that levels of GLUT1
immunoprecipitated in the assay were similar (Figure 7B; lanes
1 vs 2). Plin2 was next immunoprecipitated from each cell type
and immunoblotted with SNAP23 to show an 85% increase in
SNAP23 levels in Plin2 overexpression cells (Figure 7D; lanes
1 vs 2, Figure 7F). These results suggested that SNAP23/Plin2
interactions were enhanced when Plin2 was overexpressed.
The changes observed in the amount of SNAP23 co-
precipitated were not due to differences in the amount of Plin2
immunoprecipitated since immunoblotting with Plin2 antibody
following immunoprecipitation showed equal levels of Plin2
(Figure 7E, lanes 1 vs 2) indicating the amount of Plin2
immunoprecipitated was similar in both cell types. Experiments
were performed in the reverse by immunoprecipitating SNAP23
and immunoblotting with each antibody to show: (i) Enhanced
interaction (2 fold) between Plin2 and SNAP23 (Figure 7G,
lanes 1 vs 2, Figure 7K); (ii) Reduced interaction (37%)
between GLUT1 and SNAP23 (Figure 7H, lane 1 vs 2, Figure
7K); (iii) No interaction of SNAP23 with Plin1 (Figure 7I, lane 1
vs 2); and (iv) Levels of SNAP23 immunoprecipitated in the
assay were similar in the Plin2 overexpression and control cells
(Figure 7J, lane 1 vs 2). Taken together, these data
demonstrate increased SNAP23/Plin2 association and
SNAP23 partitioning to lipid droplets in Plin2 overexpression
cells. Thus, despite increased SNAP23 expression in cells
overexpressing Plin2, increased association and partitioning of
SNAP23 with Plin2 reduced the availability of SNAP23 to
interact with GLUT1 vesicles, thereby reducing 2-NBD-glucose
uptake in cells with increased Plin2 expression.
The effect of Plin2 expression on interactions between
SNAP23/Plin2 versus SNAP23/GLUT1 was also examined by
calculating the percent co-localization of each image pair in
control and Plin2 overexpression cells. As shown in Table 3,
when Plin2 was increased, the percent co-localization of
SNAP23 with Plin2 significantly increased from 30% to 41%
and the amount of Plin2 interacting with SNAP23 increased
from 76 to 84%. In contrast, the amount of SNAP23 co-
localized with GLUT1 decreased to 26% from 56% and to 77%
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Figure 7.  Co-immunoprecipitation of SNAP23 with GLUT1, Plin2, or Plin1.  The native proteins in cell homogenates from Plin2
overexpressing and control cells were co-immunoprecipitated as described in the Methods section. To examine SNAP23/GLUT1
interactions, GLUT1 was immunoprecipitated using anti-GLUT1. Levels of SNAP23 (A) in the immunoprecipitate from control (lane
1) and PLIN2 overexpressing cells (lane 2) were analyzed by immunoblotting with anti-SNAP23. Equal immunoprecipitation of
GLUT1 was verified by immunoblotting with anti-GLUT1 (B). The ratio of SNAP23 immunoprecipitated with GLUT1 was calculated
from the integrated density values from Western blots (C). To analyze SNAP23/Plin2 interactions, Plin2 was immunoprecipitated
with anti-Plin2 and levels of SNAP23 (D) were detected by immunoblotting with anti-SNAP23. Equal immunoprecipitation of Plin2
was verified by immunoblotting with anti-Plin2 (E). The ratio of SNAP23 immunoprecipitated with GLUT1 was calculated from the
integrated density values from Western blots (F). Reverse immunoprecipitation experiments were also performed. SNAP23 was
immunoprecipitated with anti-SNAP23 and levels of Plin2 (G), GLUT1 (H), and Plin1 (I) in the immunoprecipitate were analyzed by
Western blotting. Equal immunoprecipitation of SNAP23 was verified by immunoblotting (J). The ratio of Plin2, GLUT1 and Plin1
immunoprecipitated with SNAP23 was calculated from the integrated density values from Western blots (K). Immunoprecipitate
obtained using secondary IgG antibodies (lane 3) were used as negative controls for each set. (*) indicates p < 0.05 as compared to
control.
doi: 10.1371/journal.pone.0073696.g007
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from 91% in the reverse experiment when Plin2 levels were
increased (Table 3). These results suggested that Plin2
overexpression led to significantly increased interactions of
SNAP23 with Plin2 but diminished contact with GLUT1. In all,
these results indicated that when Plin2 levels were increased
SNAP23 partitioned to a greater extent to lipid droplets in close
association with Plin2 at the expense of SNAP23/GLUT1
interactions. Taken together, results presented herein suggest
that SNAP23 is retained on the lipid droplet surface by
enhanced interaction with Plin2 under conditions of lipid
accumulation when Plin2 expression is increased, leading to
decreased interaction at the plasma membrane and decreased
glucose uptake. A schematic diagram of these results is
depicted in Figure 8.
Discussion
While dysregulation of lipid metabolism in lipid droplet
function has been implicated in the development of obesity and
insulin resistant type 2 diabetes [56], the functional significance
of lipid droplets and associated proteins such as Plin2 in the
regulation of glucose uptake and metabolism remains largely
unknown. This is of interest since several studies with rodent
models and clinical subjects suggest that Plin2 may influence
glucose metabolism. For instance, leptin-deficient Zucker
diabetic fatty (ZDF) rats fed a high fat diet showed increased
expression of Plin2 in muscle during the progression of
diabetes [22], while Varela et al. [23] showed that development
of insulin resistance was reduced by treatment with anti-sense
oligonucleotides specific to Plin2. In line with this, leptin
deficient obese (Lepob/ob) mice crossed with mice deficient in full
length Plin2 showed improved glucose tolerance and enhanced
glucose disposal rate compared to their obese Lepob/ob
counterparts [24,25]. Another study showed that treatment of
diabetic subjects with rosiglitazone, a known insulin sensitizer
reduced levels of myocellular Plin2 content [22]. Moreover,
Faleck et al. [33] showed treatment of Plin2 anti-sense
oligonucleotides in mice decreased palmitoic acid-induced
insulin secretion from β-cells, suggesting an involvement of
Plin2 in insulin secretion from pancreatic β-cells. In general,
Table 3. Percent co-localization of SNAP23 interactions
with Plin2 versus GLUT1 in control and Plin2 over
expression cells.
 % Co-localization
Colocalization Pair Control Plin2
SNAP23:Plin2   
 % SNAP23 w/ Plin2 30 ± 3 41 ± 4*
 %Plin2 w/ SNAP23 76 ± 2 84 ± 2*
SNAP23:GLUT1   
 % SNAP23 w/ GLUT1 56 ± 4 26 ± 9*
 % GLUT1 w/ SNAP23 91 ± 3 77 ± 5*
Values represent mean ± SEM. Percent co-localization was calculated from
Olympus Fluoview software as described in the Method section. (*) indicates p <
0.05 as compared to the control cells.
these studies suggested that Plin2 can influence cellular
glucose metabolism by regulating both insulin secretion from β-
cells and insulin sensitivity of peripheral cells. However, while
these reports supported a link between Plin2 and insulin
resistance leading to diabetes, no direct experimental evidence
was given to explain these observations at the cellular level. In
the current study this issue was addressed by examining the
effect of Plin2 overexpression on glucose uptake and
metabolism. Results presented herein show for the first time
that Plin2 overexpression inhibited cellular glucose uptake 1.8-
fold in stably transfected L cells. The inhibitory effect of Plin2
was further confirmed by using a radiolabeled glucose
analogue [3H]-2-deoxyglucose, wherein a 2-fold decrease was
observed. In contrast, a complementary RNAi-mediated
knockdown approach showed nearly a 2-fold increase in
glucose uptake in both L cells and differentiated 3T3-L1 cells
with decreased Plin2 expression. Based on the kinetic
parameters derived from the fitted uptake curves, Plin2
expression regulated the extent of glucose entering the cells,
as reflected by the decreased Fmax and also influenced the
speed of uptake, as shown by the slower initial rate of uptake in
Plin2 overexpression cells. Treatment of cells with cytochalasin
B, a GLUT inhibitor decreased glucose uptake while treatment
with insulin increased uptake parameters. These results
confirmed that 2-NBD-Glucose uptake and transport in L cells
was mediated by glucose transporters and insulin. This was of
some importance since translocation of GLUT containing
secretory vesicle (GSV) from intracellular locations and fusion
to the plasma membrane are critical steps in the regulation of
glucose uptake. In the present work, a decrease in cellular
glucose uptake was observed in Plin2 overexpression cells
indicating a potential role for Plin2 in regulating this process.
Since glucose uptake and transport is dependent not only on
the insulin receptor and GLUT proteins but also on SNARE
proteins involved in the vesicular fusion machinery that
facilitate glucose uptake into the cell, it was of interest to
examine expression levels of not only the insulin receptor and
GLUT proteins, but also SNARE proteins such SNAP23,
syntaxin-5, and VAMP4 that are notably present on lipid
droplets [32]. It was also important to examine levels of fat
specific protein 27 (FSP27) in Plin2 overexpression cells since
FSP27 can facilitate lipid droplet fusion [57–59] and since
FSP27 knockout mice showed improved insulin sensitivity [60].
Moreover, FSP27 is enriched at contact sites between two lipid
droplets and has been shown to facilitate the transfer of lipids
on lipid droplet surface [61]. Levels of Plin1 were also
examined since recent reports have implicated a potential role
for Plin1 in the development of insulin resistance [62]. In one
study, older Plin1 null mice were lean and resistant to diet-
induced obesity yet developed insulin resistance [14,63]. In
other work, Puri et al. [64] reported that Plin1 mRNA levels
were decreased in visceral and subcutaneous adipose tissues
of insulin resistant obese individuals. Conversely, Kern et al.
[65] reported that obese patients with increased Plin1 in
adipocytes interspersed in skeletal muscle did not show any
change in insulin sensitivity. In addition, FSP27 has been
shown to interact with Plin1 [66] while Plin1 increases the
activity of FSP27 in the formation of unilocular LDs in
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Figure 8.  Schematic diagram for SNARE-mediated regulation of glucose transport in Plin2 overexpression cells.  Key
regulators involved in glucose uptake and transport are illustrated. Glucose transporters (GLUT) are involved in the entry of glucose
into the cells. In the absence of insulin stimulation, these transporters predominantly reside in vesicular structures that move slowly
from the cytoplasm to PM. Upon insulin stimulation GLUT-containing vesicles translocate, dock, and fuse with the plasma
membrane through the action of SNARE fusion machinery proteins including SNAP23, Syntaxin-5, and VAMP4. Similar proteins
(SNAP23, Syntaxin-4, and VAMP2) are also present on the lipid droplet surface along with Plin2 which directly interacts with
SNAP23. Under conditions of excess lipid storage that increase lipid droplet formation and Plin2 expression, SNAP23 is retained on
the lipid droplet by enhanced interaction between Plin2 and SNAP23. A decreased interaction between SNAP23 with other SNARE
proteins at the plasma membrane results in decreased glucose uptake. * Studies that show SNAP23 participate in Plin2-coated lipid
droplet fusion are described in [32,72].
doi: 10.1371/journal.pone.0073696.g008
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adipocytes [67]. In the present work, analysis of multiple
Western blots revealed that expression levels of the insulin
receptor, GLUT1 (the primary glucose transporter in L cells),
FSP27, and Plin1 were not significantly changed in Plin2
overexpression cells when compared to control cells, ruling out
effects due to altered expression of these proteins. In contrast,
expression of SNAP23 was increased in Plin2 overexpression
cells, while levels of syntaxin-5 were decreased with no
observed change in the expression of VAMP4. These results
were consistent with one study that showed RNAi-mediated
knock down of syntaxin-5 resulted in a defective insulin action
as reflected by a decrease in insulin-dependent Akt
phosphorylation in cultured human skeletal-muscle cells [68].
However, another study found increased SNAP23 expression
in the skeletal muscle of type-2 diabetic patients [69]. In the
present work, reduction in syntaxin-5 levels may have slowed
down the process of glucose transporter vesicle fusion to the
membrane, leading to the observed decreased initial rate.
However, since SNAP23 and syntaxin-5 are involved in the
docking and fusion of glucose transporters to the plasma
membrane to allow glucose uptake [30], increased SNAP23
expression would be expected to enhance glucose uptake,
contrary to the observed results. One explanation for these
counterintuitive results could be that expression levels may not
be as important as cellular localization and partitioning of these
proteins. It was recently reported that SNAP23, syntaxin-5, and
VAMP4 were present in lipid droplets and were essential for
lipid droplet fusion and growth [32]. Hence it is possible that
lipid droplets may be sharing and/or competing with the cell’s
vesicular fusion machinery for the SNARE complex proteins.
To explore this possibility, interactions between Plin2 and
SNAP23 (and also SNAP23 with GLUT1) were analyzed by
FRET imaging to determine if SNAP23 was in direct contact
with Plin2 on the lipid droplet surface. FRET, a technique
based on examining the non-radiative transmission of energy
from an excited donor molecule to a nearby acceptor molecule
that is dependent on the dipole-dipole interactions of
fluorescent donor to acceptor molecules is capable of detecting
molecule-molecule interactions at distances in the range of
10-100 Å. In the case of Cy3-labeled SNAP23 and Cy5-labeld
Plin2, the measured intermolecular distance R between the two
molecules was 51.3 + 0.4 Å (Table 3), indicating the two
proteins were in close physical association on the lipid droplet
surface. Distances between the Cy3/Cy5-labeled SNAP23/
GLUT1 pair were 60.4 + 0.3 Å, indicating close intermolecular
distances as well, but significantly more than the distance
between SNAP23/Plin2 (n=45-60 cells, P<0.001). Measured E
values, representing the efficiency of energy transfer between
donor and acceptor and dependent on the distance R and the
orientation of the donor and acceptor molecules was also
determined. The mean E was 49 ± 1% for the SNAP23/Plin2
FRET pair and 27±1% for SNAP23/GLUT1, indicating
significantly lower energy transfer occurred between the
SNAP23/GLUT1 pair (n=45-60 cells, P<0.001). E was also
quantified on a pixel-by-pixel basis in FRET image maps to
identify specific areas within the cell where the percentage of E
was highest. For the SNAP23/Plin2 pair, areas of the cell
overlapping with lipid droplets showed the highest E values
ranging from 40–50% on the FRET efficiency scale (Figure
5E). With the SNAP23/GLUT1 pair, FRET occurred in diffused
areas throughout the cell with E significantly lower (in the
20-30% range) than observed with SNAP23/Plin2 pair (Figure
6E). Thus, FRET imaging studies indicated a direct interaction
between SNAP23 and Plin2 on the surface of lipid droplets and
a more diffuse pattern of SNAP23/GLUT1 interaction in areas
outside the lipid droplet.
The ability of SNAP23 to partition selectively between lipid
droplets and the plasma membrane was also examined in a
series of co-IP and co-localization experiments in order to
explain how enhanced expression of Plin2 and SNAP23 could
lead to decreased cellular glucose uptake in transfected cells.
Based on the results from multiple co-IP experiments,
interactions between Plin2 and SNAP23 were enhanced when
expression of Plin2 was increased. Concomitantly, partitioning
of SNAP23 with GLUT1 was decreased in Plin2
overexpression cells, suggesting that in the presence of Plin2
overexpression, SNAP23 was less available for vesicular
fusion at the plasma membrane resulting in less cellular
glucose uptake. In keeping with these results, when the
percent co-localization and extent of overlap between SNAP23/
Plin2 versus SNAP23/GLUT1 were examined, the percent co-
localization and overlap coefficient between the SNAP23/Plin2
pair were significantly increased while SNAP23/GLUT1
interactions were significantly decreased when Plin2 was
present at higher levels. Taken together, these results suggest
that when Plin2 levels were increased SNAP23 partitioned to a
greater extent to Plin2-associated lipid droplets at the expense
of SNAP23/GLUT1 interactions. It should be noted that the
current work did not show direct evidence that increased
SNAP23/Plin2 interactions correlated with decreased GLUT1
on the plasma membrane and this represents a limitation to the
study. Moreover, mechanisms underlying the relationship
between insulin dependent GLUT4 and Plin2-coated LD could
not be addressed based on the data presented. Future studies
are planned to investigate these issues in more detail.
Nevertheless, other work has shown that treatment of cardiac
cells with oleic acid (which increased lipid droplet size and
number) significantly reduced SNAP23 at the plasma
membrane while increasing its presence in lipid droplets,
resulting in reduced insulin-stimulated glucose uptake [32].
Moreover, increased partitioning of SNAP23 to cytosolic/
microsomal compartments and reduced SNAP23 expression at
the plasma membrane was also observed in studies using
muscle cells of type-2 diabetic patients [69]. In keeping with
this, it was recently demonstrated that α-synuclein null mice
that are resistance to diet induced obesity showed decreased
lipid droplet size because of reduced SNARE complex
formation in adipocytes, further highlighting the role of SNARE
proteins in lipid droplet formation and fusion [70]. It should be
noted however, another report revealed FSP27 and Plin1
interact with each other and are involved in the formation of
unilocular lipid droplets [66]. Interestingly, while FSP27
interacts with Plin1, it does not seem to interact with Plin2 as
studied by co-immunoprecipitation experiments [67]. Hence,
given the mutually exclusive presence of Plin1 and Plin2 on
lipid droplets, it is possible that FSP27/Plin1 interactions may
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be primarily involved in the formation of unilocular lipid
droplets, while SNAP23/Plin2 interactions may direct the
formation of multilocular lipid droplets. Further studies are
warranted to test if such distinct mechanisms exist in lipid
droplet fusion. In this regard, it is interesting to note that knock
down of SNAP23 in S2 cells had no effect on unilocular LD
formation [71]. Although further studies may be needed to
ascertain the role of SNAP23 in lipid droplet fusion, data from
the present work suggests that Plin2 influences cellular glucose
uptake and transport by re-directing SNAP23 to lipid droplets.
In summary, the current investigation provides a fresh
mechanistic view of the role of lipid droplets and associated
proteins in cellular metabolism by demonstrating the following
novel insights. First, insulin-mediated cellular glucose uptake
inversely correlates to Plin2 expression in cells without altered
levels of the insulin receptor, glucose transporters, or other lipid
droplet-associated proteins. Second, levels of the SNARE
complex protein SNAP23 was significantly increased in Plin2
overexpression cells, results at odds with the decreased uptake
data but explained by increased partitioning of SNAP23 with
Plin2 on the lipid droplet surface where SNAP23 was shown to
be in direct physical association with Plin2. Concomitantly,
interactions with SNAP23 and GLUT1 were decreased in Plin2
overexpression cells, suggesting that expression levels of Plin2
may regulate the availability of SNAP23 for vesicular fusion at
the plasma membrane. Taken together, these data suggest
that Plin2 influences cellular glucose uptake and transport by
interacting with, and regulating cellular targeting of various
SNARE proteins. Since insulin resistance can be characterized
by inefficient glucose uptake into muscle and fat cells, the
observed changes in insulin-stimulated glucose uptake due to
altered Plin2 expression gives support to the premise that Plin2
may play an important physiological role in regulating cellular
insulin resistance.
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